Posts

Highlights of the National Vein Congress

The La Jolla Vein Care doctors and staff attended the American College of Phlebology (ACP) Annual Conference in Phoenix last week.  More than 1,000 vein care practitioners from the United States and around the world attended the meeting to share information and research in the field of vein disorders (also known as phlebology).  The speakers included vein and vascular experts from around the world, include La Jolla Vein Care’s Dr. Fronek.  Dr. Bunke was featured in the daily congress newsletter as being the first physician to complete a specialized Fellowship program in the field of Phlebology.

La Jolla Vein Care’s medical assistants and vascular sonographers attended also to learn the most update information on a variety of vein topics including; complications in sclerotherapy, the swollen limb, thrombophilia, new anticoagulants, venous stents, compression therapy, vascular ultrasound, foam and liquid sclerotherapy, vascular malformations, lymphedema, venous system during pregnancy, venous skin changes, dvt and superficial thrombophlebitis, chronic venous insufficiency and research on specific vascular topics.

 

 

 

Blood Clotting Mutation Affects 1-2% of the Population

A point mutation (G20210A) in the Factor II (prothrombin) gene is the second most common cause of inherited blood clots and accounts for 20% of the inherited blood clotting disorders. The incidence of this mutation in the Caucasian population is 1-2% and in African Americans it is 0.1%. Carriers of this mutation have an increased risk (3x) of developing a blood clot in the deep veins (deep venous thrombosis or DVT).  A test for this mutation is usually only recommended if there is a family history of blood clots (DVT) or in cases where the cause of the blood clot is not clear or in pregnant women with recurrent miscarriages.  A more common cause of a blood clotting disorder that is inherited from the parents is the Factor V Leiden mutation.